T.Man Pharmaceutical Past Earnings Performance
Past criteria checks 3/6
T.Man Pharmaceutical has been growing earnings at an average annual rate of 35%, while the Pharmaceuticals industry saw earnings growing at 10.4% annually. Revenues have been growing at an average rate of 7.5% per year. T.Man Pharmaceutical's return on equity is 23.8%, and it has net margins of 19.7%.
Key information
35.0%
Earnings growth rate
14.0%
EPS growth rate
| Pharmaceuticals Industry Growth | 12.4% |
| Revenue growth rate | 7.5% |
| Return on equity | 23.8% |
| Net Margin | 19.7% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How T.Man Pharmaceutical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 2,130 | 419 | 492 | 0 |
| 31 Mar 24 | 2,055 | 425 | 472 | 0 |
| 31 Dec 23 | 1,980 | 431 | 452 | 0 |
| 30 Sep 23 | 1,909 | 416 | 440 | 0 |
| 30 Jun 23 | 1,982 | 494 | 426 | 0 |
| 31 Mar 23 | 2,003 | 483 | 459 | 0 |
| 31 Dec 22 | 2,025 | 473 | 493 | 0 |
| 31 Dec 21 | 1,263 | 56 | 321 | 0 |
| 31 Dec 20 | 901 | 60 | 254 | 0 |
Quality Earnings: TMAN-F has high quality earnings.
Growing Profit Margin: TMAN-F's current net profit margins (19.7%) are lower than last year (24.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: TMAN-F's earnings have grown significantly by 35% per year over the past 5 years.
Accelerating Growth: TMAN-F's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: TMAN-F had negative earnings growth (-15.1%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (5.9%).
Return on Equity
High ROE: TMAN-F's Return on Equity (23.8%) is considered high.